Diagnos Inc Total Assets
Diagnos Inc total assets. Based on the latest financial reports, Diagnos Inc (ADK) holds total assets worth CA$1.17 Million CAD (≈ $847.95K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Diagnos Inc for the company's overall valuation and market capitalisation.
Total Assets of Diagnos Inc (2002–2025)
Total assets of Diagnos Inc from 2002 to 2025. This chart illustrates how Diagnos Inc's total assets have evolved over time, based on quarterly financial data. See latest Diagnos Inc stock price today for real-time trading data and today's change.
Diagnos Inc - Asset Composition Analysis
Diagnos Inc Total Assets Breakdown (March 2025)
Diagnos Inc total assets breakdown as of March 2025. Diagnos Inc's total assets of CA$1.17 Million consist of 95.3% current assets and 4.7% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 2.4% |
| Accounts Receivable | CA$10.41K | 0.3% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Diagnos Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ADK working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Diagnos Inc's current assets represent 95.3% of total assets in 2025, an increase from 21.6% in 2002.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2025, up from 2.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 0.3% of total assets.
Diagnos Inc Competitors by Total Assets
Key competitors of Diagnos Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
KNEAT.COM INC.
F:FOBK
|
Germany | €121.76 Million |
|
Intrasense
PA:ALINS
|
France | €7.99 Million |
|
Enlitic Inc
AU:ENL
|
Australia | AU$14.60 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
Diagnos Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.39 | 1.09 | 2.82 |
| Quick Ratio | 0.39 | 1.09 | 2.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-1.45 Million | CA$227.68K | CA$1.06 Million |
Diagnos Inc - Advanced Valuation Insights
This section examines the relationship between Diagnos Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 111.43 |
| Latest Market Cap to Assets Ratio | 6.79 |
| Asset Growth Rate (YoY) | 447.8% |
| Total Assets | CA$3.64 Million |
| Market Capitalization | $24.68 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Diagnos Inc's assets at a significant premium (6.79x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Diagnos Inc's assets grew by 447.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Diagnos Inc (2002–2025)
The table below shows the annual total assets of Diagnos Inc from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | CA$3.64 Million ≈ $2.63 Million |
+447.78% |
| 2024-03-31 | CA$663.79K ≈ $480.17K |
-19.35% |
| 2023-03-31 | CA$823.03K ≈ $595.37K |
-46.61% |
| 2022-03-31 | CA$1.54 Million ≈ $1.12 Million |
-20.96% |
| 2021-03-31 | CA$1.95 Million ≈ $1.41 Million |
-19.87% |
| 2020-03-31 | CA$2.43 Million ≈ $1.76 Million |
+101.63% |
| 2019-03-31 | CA$1.21 Million ≈ $873.23K |
-20.80% |
| 2018-03-31 | CA$1.52 Million ≈ $1.10 Million |
+16.42% |
| 2017-03-31 | CA$1.31 Million ≈ $947.09K |
+3.04% |
| 2016-03-31 | CA$1.27 Million ≈ $919.15K |
+8.39% |
| 2015-03-31 | CA$1.17 Million ≈ $848.00K |
-25.71% |
| 2014-03-31 | CA$1.58 Million ≈ $1.14 Million |
-28.98% |
| 2013-03-31 | CA$2.22 Million ≈ $1.61 Million |
-16.21% |
| 2012-03-31 | CA$2.65 Million ≈ $1.92 Million |
+75.17% |
| 2011-03-31 | CA$1.51 Million ≈ $1.10 Million |
-33.42% |
| 2010-03-31 | CA$2.27 Million ≈ $1.64 Million |
-14.61% |
| 2009-03-31 | CA$2.66 Million ≈ $1.93 Million |
-45.34% |
| 2008-03-31 | CA$4.87 Million ≈ $3.52 Million |
+204.16% |
| 2007-03-31 | CA$1.60 Million ≈ $1.16 Million |
+66.10% |
| 2006-03-31 | CA$964.27K ≈ $697.54K |
+155.93% |
| 2005-03-31 | CA$376.77K ≈ $272.55K |
-47.08% |
| 2004-03-31 | CA$711.90K ≈ $514.98K |
+183.79% |
| 2003-03-31 | CA$250.86K ≈ $181.47K |
-27.68% |
| 2002-03-31 | CA$346.87K ≈ $250.92K |
-- |
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more